Period
recent search
Showing: 1 – 05 of 171 Regulated Information
23 August 2022
23 August 2022
LinkedIn
Facebook
Share buyback program – Ipsen reporting from 15 to 19 August 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
12 August 2022
12 August 2022
LinkedIn
Ipsen completes acquisition of Epizyme expanding its portfolio in oncology
PARIS, FRANCE, 12 August 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced the closing of the definitive merger agreement under which Ipsen has acquired Epizyme, Inc. (Epizyme). Pursuant to the transaction, Ipsen acquires all outstanding shares of Epizyme for $1.45…
09 August 2022
09 August 2022
LinkedIn
Voting rights on 31 July 2022
This article or press release has no online content. Please download the associated documents for more information.
09 August 2022
09 August 2022
LinkedIn
Share buyback program – Ipsen reporting from 01 to 05 August 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
05 August 2022
05 August 2022
LinkedIn
Ipsen extends expiration date of tender offer for Epizyme, Inc. to 11 August 2022
PARIS, FRANCE, 5 August 2022 – Ipsen S.A. (Euronext: IPN; ADR: IPSEY) today announced that Hibernia Merger Sub, Inc. (Purchaser), its wholly owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the…